Lawsuit for Investors in (NASDAQ: PBYI) Shares Against Puma Biotechnology Inc. Announced by Shareholders Foundation

SAN DIEGO, CA / ACCESSWIRE / June 5, 2017 / The Shareholders Foundation, Inc. announces that a lawsuit was filed for investors who purchased (NASDAQ: PBYI) shares against Puma Biotechnology Inc. over alleged Securities Laws Violations.

The plaintiff seeks to recover losses for certain investors who purchased NASDAQ: PBYI shares.

Investors who purchased shares of Puma Biotechnology Inc. (NASDAQ: PBYI) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.

On May 4, 2017, Puma Biotechnology, Inc. disclosed the resignation of Dr. Robert Charnas, the Company’s Senior Vice President, Regulatory Affairs, citing “health reasons.” Dr. Charnas’ resignation will be effective as of May 15, 2017, nine days before the FDA scheduled review of Puma Biotechnology, Inc’s breast cancer drug neratinib on May 24.

On May 8, 2017, a lawsuit was filed against Puma Biotechnology Inc. (NASDAQ: PBYI) over alleged securities laws violations. The plaintiff claims that the defendants made false and/or misleading statements and/or failed to disclose that the Company did not anticipate that the U.S. Food and Drug Administration’s (“FDA”) would ultimately approve neratinib for the treatment of breast cancer, that as such, Puma had overstated the drug’s approval prospects and/or commercial viability, and that as a result, Puma’s public statements were materially false and misleading at all relevant times.

Those who purchased Puma Biotechnology Inc. (NASDAQ: PBYI) shares should contact the Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

CONTACT:

Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
mail@shareholdersfoundation.com
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108

SOURCE: Shareholders Foundation, Inc.

ReleaseID: 464799